Chiquita Brooks-LaSure, CMS director (Caroline Brehman/CQ Roll Call via AP Images)
Ahead of lecanemab decision, Alzheimer's groups petition CMS to reverse coverage policy
Aduhelm’s successor is now weeks away from its PDUFA date — and several advocacy groups are arguing for the reversal of a controversial CMS policy. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
